# HFS (High-Fiber Supplement) in MS (Multiple Sclerosis)

> **NCT04574024** · PHASE1,PHASE2 · COMPLETED · sponsor: **Suhayl Dhib-Jalbut, MD** · enrollment: 7 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** NBT-NM108

## Key facts

- **NCT ID:** NCT04574024
- **Lead sponsor:** Suhayl Dhib-Jalbut, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-21
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-07-15
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04574024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04574024, "HFS (High-Fiber Supplement) in MS (Multiple Sclerosis)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04574024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*